(Q46359710)

21 December 2017

title

Plasma YKL-40: a potential biomarker for psoriatic arthritis? (English)

1 reference

21 December 2017

0 references

1 reference

7

L Skov

1 reference

21 December 2017

P Jensen

1

1 reference

21 December 2017

C Wiell

2

1 reference

21 December 2017

K Milting

3

1 reference

21 December 2017

R P Poggenborg

4

1 reference

21 December 2017

M Østergaard

5

1 reference

21 December 2017

J S Johansen

6

1 reference

21 December 2017

publication date

23 May 2012

1 reference

21 December 2017

Journal of the European Academy of Dermatology and Venereology

published in

1 reference

21 December 2017

volume

27

1 reference

21 December 2017

issue

7

1 reference

21 December 2017

page(s)

815-819

1 reference

21 December 2017

Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Plasma YKL-40: a potential new cancer biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

IL-6, but not TNF-α, increases plasma YKL-40 in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Chitinase-like proteins are autoantigens in a model of inflammation-promoted incipient neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Plasma YKL-40: a BMI-independent marker of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

A chitinase-like protein in the lung and circulation of patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04570.X

10.1111/J.1468-3083.2012.04570.X

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017